Article Details
Retrieved on: 2021-08-05 14:45:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche's rationale for combining atezolizumab with a SY-5609 is backed by preclinical data showing that CDK7 inhibition leads to DNA replication stress ...
Article found on: www.precisiononcologynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here